1202243

Karyopharm Therapeutics Inc. — FEI 3012640137

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 15, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Newton, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)